Micot Pharma-B (02335.HK): Grey Market Surges 84.18% to HK$33.52
NewTimeSpace News: Micot Pharma-B (02335.HK) commenced grey market trading today. As of press time, its grey market quotation stood at HK$33.52, representing an increase of HK$15.32 or 84.18% compared with the IPO offer price of HK$18.20.
NewTimeSpace News: Grey market trading for Micot Pharma-B (02335.HK) launched on 23 June 2026, with official listing scheduled for 24 June 2026.
The IPO offer price is HK$18.20 per share, and each trading lot contains 200 shares. As of press time, the grey market price was quoted at HK$33.52, up HK$15.32, equivalent to a gain of 84.18%.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- MICOT PHARMA-B (02335.HK): Preclinical and Phase I data of neuroprotective candidate MT200605 accepted for oral presentation at 2026 World Stroke Congress; Phase II meets primary endpoint
- MICOT PHARMA-B(02335.HK) closed 102.75% higher, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends
- ETF Financing Ranking | China Southern CSI SWS Non-Ferrous Metal ETF (512400) had a net financing buy-in of CNY 40.3 million on Aug 10, ranked in the first tier of the entire market
- ETF Financing Ranking | Huaan SZSE ChiNext Composite 50 ETF (159949) had a net financing buy-in of CNY 55.57 million on Aug 10, ranked top among comparable funds
- ETF Financing Ranking | Huatai-PB CSOP Hang Seng Technology ETF(QDII) (513130) had a net financing buy-in of CNY 78.8 million on Aug 10, ranked top among comparable funds
